Results 121 to 130 of about 6,190,215 (306)

Modelling anaerobic peak power assessed by the force-velocity test among late adolescents. [PDF]

Rev Assoc Med Bras (1992), 2023
Martinho DV, Baptista R, Teixeira AS, Oliveira T, Oliveira T, Valente-Dos-Santos J, Coelho-E-Silva MJ, Cupido-Dos-Santos A.   +7 more
europepmc   +1 more source

Deep Learning Pose Estimation for Phenotyping of Co‐Occurring Hyperkinetic Movement Disorders

Annals of Clinical and Translational Neurology, EarlyView.
ABSTRACT Objective To explore whether routine outpatient video combined with deep learning‐based pose estimation and clinically interpretable kinematic features can support multi‐label phenotyping of co‐occurring hyperkinetic movement disorders (HMDs).
Laura Cif, Diane Demailly, Gabriella A. Horvàth, Juan Dario Ortigoza Escobar, Nathalie Dorison, Mayté Castro Jiménez, Cécile A. Hubsch, Thomas Wirth, Gun‐Marie Hariz, Sophie Huby, Morgan Dornadic, Zohra Souei, Muhammad Mushhood Ur Rehman, Simone Hemm, Mehdi Boulaymen, Eduardo M. Moraud, Jocelyne Bloch, Xavier Vasques   +17 more
wiley   +1 more source

High-resolution imaging enabled by 100-kW-peak-power parametric source at 5.7 THz. [PDF]

Sci Rep, 2023
Kuo CH, Wu MH, Chen CR, Lin YJ, Laurell F, Huang YC.   +5 more
europepmc   +1 more source

Reliability of a cycle ergometer peak power test in running-based team sport athletes: a technical report

, 2015
Given the importance of ensuring athletes train and compete in a nonfatigued state, reliable tests are required to regularly monitor fatigue. The purpose of this study was to investigate the reliability of a cycle ergometer to measure peak power during ...
Wehbe, George M., Hartwig, Timothy B., McLellan, Christopher P., Gabbett, Tim J.   +3 more
core   +1 more source

Natural Frequencies of Levodopa‐Induced Dyskinesia in Parkinson's Disease

Annals of Clinical and Translational Neurology, EarlyView.
ABSTRACT Objectives Abnormal involuntary movements, known as dyskinesias, are common complications of levodopa treatment in patients with Parkinson's disease and can significantly impair quality of life. The underlying pathophysiology remains unclear, and current therapeutic options are limited.
Ioannis U. Isaias, Federica Avantaggiato, Gianni Pezzoli, Andrea Canessa   +3 more
wiley   +1 more source

Design optimization of powered ankle prosthesis to reduce peak power requirement. [PDF]

Sci Prog, 2022
Bilal M, Rizwan M, Maqbool HF, Ahsan M, Raza A.   +4 more
europepmc   +1 more source

Global Rather Than Vertical‐Selective Saccadic Abnormalities in Progressive Supranuclear Palsy

Annals of Clinical and Translational Neurology, EarlyView.
ABSTRACT Objective To test whether vertical saccades are preferentially affected in Progressive Supranuclear Palsy (PSP). Methods PSP patients (n = 24) were compared to age‐matched controls (n = 94) and two degenerative groups (Alzheimer's disease, n = 20; Lewy body disease, n = 50).
Duy Duan Nguyen, Mark Paine, Soohyun Lee, Amir Fazlollahi, Baibin (Ben) Wang, John D. O'Sullivan, Peter J. Nestor   +6 more
wiley   +1 more source

Chip-scale high-peak-power semiconductor/solid-state vertically integrated laser. [PDF]

Nat Commun, 2022
Yue J, Tanaka K, Hirano G, Yonezawa G, Shimizu M, Iwakoshi Y, Tobita H, Koda R, Higa Y, Watanabe H, Yanashima K, Kamata M.   +11 more
europepmc   +1 more source

Integrated PANoptosis Profiling Identifies Immunosuppressive Subtypes and a Prognostic Signature With Functional Validation of MLKL in Glioblastoma

Annals of Clinical and Translational Neurology, EarlyView.
ABSTRACT Objective The prognosis of glioblastoma (GBM) remains highly unfavorable, largely due to high tumor heterogeneity and an immunosuppressive microenvironment. However, the functional role of PANoptosis in this context is poorly understood. Methods Patients were stratified via K‐means clustering. A risk score model was constructed using prognosis‐
Langfei Tian, Minghui Zhao, Yuanbo Hu, Kaiyue Wang, Haiguang Liu, Zetong Bai, Kebin Zheng   +6 more
wiley   +1 more source

Prediction of Rowing Functional Threshold Power Using Body Mass, Blood Lactate and GxT Peak Power Data. [PDF]

Int J Exerc Sci, 2023
McGRATH E, Mahony N, Fleming N, Donne B.
europepmc   +1 more source